2 July 1987
COMMERCIAL ITEM DESCRIPTION
DIATRIZOATE SODIUM INJECTION, USP
The General Services Administration has authorized the use of this Commercial Item Description.
Shall be Diatrizoate Sodium Injection, USP.
Shall be in accordance with the requirements of the USP.
All ingredients shall be of pharmaceutical grade.
For Strength 1, shall be an injection containing 25 percent weight/volume concentration of Diatrizoate Sodium with the applicable assay limits. Injection shall also contain 15 percent weight/volume iodeine within the applicable assay limits.
For Strength 1, Type I shall be supplied without an infusion set. The stopper of the glass container shall accept and retain the piercing device of the following Intravenous Injection Sets:
For Strength 1, Type II, shall be supplied with an infusion set. The needle size shall be 18 gage by 1-1/2 inches.
For Strength 2, shall be a 50 percent weight/volume concentration of Diatrizoate Sodium, within the applicable assay limits. Injection shall also contain 30 percent weight/volume iodine within the applicable assay limits.
Workmanship. The injection shall be free from defects which detract from its appearance or impair its serviceability.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business